Home-stay orders intended to prevent the spread of coronavirus can end up causing “irreparable damage” if imposed for too long, White House health adviser Dr. Anthony Fauci on CNBC on Friday.
“I don’t want people to think that any of us will feel that staying locked for a long time is the way to go,” Fauci said in an interview with CNBC’s Meg Tirrell on “Halftime Report . “
He said the United States would have to institute serious measures as the Covid-19 cases explode in time. “But now is the time, depending on where you are and what your situation is, to start taking a serious look at opening up the economy again, reopening the country to try to return to some level of normalcy.”
However, Fauci also warned states against reducing social change measures very quickly, adding that they should take “very important precautions.”
“In general, I think most of the country is doing it in a very careful way,” he said. “There are obviously a few situations where people can jump. I’m just saying to proceed with caution if you do.”
Just last week, Fauci warned members of Congress that the United States could face more “suffering and death” from the coronavirus if some states rushed to reopen businesses.
It could also prevent states from “on the road to trying to recover from an economic recovery,” he testified in a hearing before the Senate Committee on Health, Education, Labor and Pensions on May 12. “It is about to return the clock. . rather than going forward. That’s my main concern. “
The virus, which appeared in Wuhan, China less than five months ago, has infected more than 1.5 million people in the United States, according to data compiled by Johns Hopkins University. States have begun the process of reopening their economies after shutting down for weeks.
In a separate interview with NPR earlier in the day, Fauci said it was “conceivable” that the U.S. could start rolling out a coronavirus vaccine in December.
He told CNBC that Biotech firm vaccine data Moderna, released earlier this week, was encouraging.
Moderna is fast tracking the National Institutes of Health to develop a vaccine.
On Monday, the company released data from the phase one human trial on the potential vaccine, showing all 45 patients enrolled to produce binding antibodies seen at similar levels to humans. recovering from the virus.
The vaccine made neutralizing antibodies, which researchers believe is important to protect against the virus, for eight of the patients whose data are available to date. Data on neutralizing antibodies for the remaining patients are expected to emerge later.
“We are still far from clear,” Fauci said Friday. “There are a lot of things that need to be done. We are quickly going through a phase three trial maybe at the beginning of the summer, sometime in July.”